AFL logo

Aflac Incorporated Stock Price

NYSE:AFL Community·US$58.4b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 70 Fair Values set on narratives written by author

AFL Share Price Performance

US$113.40
6.44 (6.02%)
US$111.86
Fair Value
US$113.40
6.44 (6.02%)
1.4% overvalued intrinsic discount
US$111.86
Fair Value
Price US$113.40
AnalystConsensusTarget US$111.86

AFL Community Narratives

·
Fair Value US$111.86 1.4% overvalued intrinsic discount

AFL: Earnings Stability And Strong Buybacks Will Support Balanced Outlook

1users have liked this narrative
0users have commented on this narrative
33users have followed this narrative
US$111.86
1.4% overvalued intrinsic discount
Revenue
-0.14% p.a.
Profit Margin
20.86%
Future PE
16.67x
Price in 2029
US$136.94

Trending Discussion

Updated Narratives

AFL logo

AFL: Future Returns Will Balance Reinsurance Moves With Cautious Earnings Expectations

Fair Value: US$111.86 1.4% overvalued intrinsic discount
33 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet established dividend payer.

2 Risks
2 Rewards

Aflac Incorporated Key Details

US$18.1b

Revenue

US$9.0b

Cost of Revenue

US$9.1b

Gross Profit

US$4.4b

Other Expenses

US$4.6b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 06, 2026
9.08
50.05%
25.60%
26.3%
View Full Analysis

About AFL

Founded
1955
Employees
12716
CEO
Daniel Amos
WebsiteView website
www.aflac.com

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

Recent AFL News & Updates

Seeking Alpha May 06

Aflac: An Insurer To Buy After Impressive Q1 Results, Even As Valuation Rises

Summary Aflac remains a Buy despite a Q1 earnings miss, supported by organic policy growth, proven dividend increases, and robust balance sheet strength. Growth catalysts include new policy sales, expanding Asian market presence, and niche segments like pet insurance, though revenue trends remain uneven. Margins and expense ratios are favorable, with A-level credit ratings and conservative leverage, but forward P/E multiples signal some overvaluation and more muted near-term upside. Dividend growth (+16% YoY) and a low payout ratio (~30%) reinforce AFL's appeal for income investors, while technicals support a bullish trend as well after a recovery signal. Read the full article on Seeking Alpha
Narrative Update May 01

AFL: Future Returns Will Balance Reinsurance Moves With Cautious Earnings Expectations

Narrative Update on Aflac The consensus analyst price target for Aflac has edged lower by a few dollars to $111.86, as analysts factor in more cautious revenue growth assumptions alongside slightly stronger profit margin and future P/E inputs. Analyst Commentary Recent research on Aflac reflects a mixed but mostly cautious tone, with several firms trimming price targets by small amounts and one lifting its target and reinitiating coverage at a neutral stance.

Recent updates

No updates